Table 8.

Summary table, associations between accelerometer measures and metabolic outcomes derived from clinical investigation and fasting blood samples measured by linear models with age, sex and BMI included in the analyses.

	Insulin	HOMA-IR	Glucose	HbA1c	Triglycerides	HDL	LDL	Cholesterol	RHR	SBP	DBP
Sedentary %	↑	↑	ns	ns	↑	↓	ns	ns	ns	ns	ns
Sedentary time	ns	ns	ns	ns	ns	↓	ns	ns	ns	ns	ns
Standing %	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns
Standing time	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns
LPA %	↓	↓	ns	ns	↓	↑	ns	ns	ns	ns	ns
LPA time	↓	↓	ns	ns	↓	↑	ns	ns	ns	ns	ns
MVPA %	↓	↓	ns	ns	ns	ns	ns	ns	ns	ns	ns
MVPA time	↓	↓	ns	ns	ns	↑	ns	ns	ns	ns	ns
PA %	↓	↓	ns	ns	↓	↑	ns	ns	ns	ns	ns
PA time	↓	↓	ns	ns	↓	↑	ns	ns	ns	ns	ns
Steps/day	↓	↓	ns	ns	ns	↑	ns	ns	ns	ns	ns
Breaks in sedentary time	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns	ns
MET mean/day	↓	↓	ns	ns	↓	↑	ns	ns	ns	ns	ns
MET peak/day	↓	↓	ns	ns	ns	ns	ns	ns	ns	ns	ns

For lipid-related outcomes, the possible use of cholesterol-lowering medication (statins) was included the model; and for blood pressure-related outcomes, the possible presence of medical treatment of hypertension was included the model.

HOMA-IR homeostasis model for insulin resistance, HbA1c glycated hemoglobin, HDL high density lipoprotein, LDL low density lipoprotein, RHR resting heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, ns non-significant, LPA light physical activity, MVPA moderate to vigorous physical activity, PA physical activity (LPA and MVPA together), MET the metabolic equivalent.

The significant positive and negative associations are indicated by upward ↑ and downward ↓ arrows, respectively.